
Aeolus Pharmaceuticals: Developing catalytic antioxidants for oncology and various disorders.
Aeolus Pharmaceuticals, founded with the mission to develop catalytic antioxidants, focuses on creating treatments for oncology, central nervous system, respiratory, and autoimmune disorders. The company aims to leverage its proprietary technology to address unmet medical needs in these areas, offering innovative solutions that enhance patient outcomes and quality of life.
Notable affiliated individuals and investors include experts in biopharmaceuticals and healthcare investment firms. Aeolus Pharmaceuticals has achieved significant milestones in preclinical and clinical development stages, contributing valuable research to the medical community. Its impact lies in advancing therapeutic options for complex diseases, potentially transforming standard care practices and improving patient prognosis.

Aeovian Pharmaceuticals
aeovian.com

Eolo Pharma
eolo-pharma.com

Aulos Bioscience
aulosbio.com

Woolsey Pharmaceuticals
woolseypharma.com

Alkeus Pharmaceuticals
alkeus.com

Aquavit Pharmaceuticals
aquavitpharma.com

Alcinous Pharmaceuticals

AstraZeneca
astrazeneca.com

Aria Pharmaceuticals

Axikin Pharmaceuticals

Aether Therapeutics

Thetis Pharmaceuticals
thetispharma.com

Altheus Therapeutics

PleoPharma
pleopharma.com

Aurora Pharmaceutical
Companies similar to Aeolus Pharmaceuticals include Aeovian Pharmaceuticals, Eolo Pharma, Aulos Bioscience and Woolsey Pharmaceuticals.
Aeolus Pharmaceuticals was founded in 1995.
Aeolus Pharmaceuticals' headquarters is located in Mission Viejo, CA, US.
Aeolus Pharmaceuticals' most recent funding round was for $6.8M (USD) in December 2015.
As of Dec 14, 2015, Aeolus Pharmaceuticals has raised a total of $18.5M (USD).